The Faculty of Pharmacy at University of Basrah organized a discussion on new treatments for osteoporosis with the participation of researchers And specialists. The panel discussion included a lecture by Dr. Ronk Adel Yassin through which she explained that the disease of fragility Bones are a common silent disease that occurs as a result of many causes, including in postmenopausal women as a result of a decrease Estrogen and older men and women as a result of increased bone destruction for bone building may be caused by fragility Bone is a corticosteroid treatment that causes osteoporosis when misused. The objective of the panel discussion is to clarify Treatment of osteoporosis are two types of treatment antiresorptive drug and anabolic drug type I prevents demolition The bone and the second type is the new and the only type that helps to build a new bone as efficiently as the old bone, which is a drug. Recombinant parathyroid hormone:teriparatide and although the benefit of this drug is not without One of the disadvantages that reduces its use is the very high price of the drug as well as the method of giving the drug For daily injections under the skin once daily in the abdomen or upper arm.